Skip to main content
Log in

In vitro tocolytic activity of 3-benzamido-1-(4-(2-methoxyphenyl)-piperazin-1-yl)-propyl-2-isopropylcarboxamide

  • The Search for New Drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The synthesis of 3-benzamido-1-(4-(2-methoxyphenyl) piperazin-1-yl)-propyl-2-isopropylcarboxamide (BPC) was accomplished by treating N-3-(4-(2-methoxyphenyl)piperazin-1-yl)-propyl-2-isopropylphthalimide with isopropylamine in dimethylformamide at room temperature. The compound was characterized spectroscopically. At concentrations of 0.05 and 0.1 mg/ml, 3-benzamido-1-(4-(2-methoxyphenyl)piperazin-1-yl)-propyl-2-isopropylcarboxamide (BPC) produced a significant inhibition of oxytocin (p < 0.05) and acetylcholine (p < 0.0001) induced contractions of the uterine smooth muscle in non-pregnant rats in a dose-dependent manner. From the results obtained it may be inferred that this compound is probably acting via muscarinic receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. D. Beckman, J. M. Thorp Jr., K. N. Lohr, et al., Am. J. Obstet. Gynec., 188(6), 1648–1659 (2003).

    Article  CAS  Google Scholar 

  2. M. Hall, P. Danielian, and R. Lamont, in: Elder M., Lamont R., and Romero R. (eds.), The Importance of Preterm Birth, Churchill Livingstone, New York (1997), pp. 1–28.

    Google Scholar 

  3. M. McLean, A. Bisits, J. Davies, et al., Nat. Med., 1, 460–463 (1995).

    Article  PubMed  CAS  Google Scholar 

  4. M. McLean, W. A. Walters, and R. Smith, Obstet. Gynec. Surv., 48, 209–225 (1993).

    Article  CAS  Google Scholar 

  5. R. Smith, S. Mesiano, and S. McGrath, Regul. Pept., 108, 159–164 (2002).

    Article  PubMed  CAS  Google Scholar 

  6. T. C. Tan, K. Devendra, L. K. Tan, et al., Singapore Med. J., 47(5), 361–366 (2006).

    PubMed  CAS  Google Scholar 

  7. The Worldwide Atosiban versus beta-Agonists Study Group: Effectiveness and safety of the oxytcin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labor, Br. J. Obstet. Gynaec., 108, 133–142 (2003).

    Google Scholar 

  8. T. M. Goodwin and A. Zograbyan, Clin. Perinatol., 25, 859–871 (1998).

    PubMed  CAS  Google Scholar 

  9. P. S. Kumar, K. Soni, and M. N. Saraf, Indian J. Pharm. Sci., 68, 190–194 (2006).

    Article  Google Scholar 

  10. M. K. Schwarz and P. Page, Curr. Med. Chem., 10, 1441–1468 (2003).

    Article  PubMed  CAS  Google Scholar 

  11. M. Vatish and S. Thornton, Exp. Opin. Ther. Patents, 12, 1403–1406 (2002).

    Article  CAS  Google Scholar 

  12. L. O. Okunrobo and C. O. Usifoh, Acta Pol. Pharm., 63, 201–205 (2006).

    CAS  PubMed  Google Scholar 

  13. D. J. H. Veale, D. W. Oliver, N. S. Arangics, and K. J. Furman, J. Ethnopharmacol., 37, 341–346 (1989).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Okunrobo O. Lucky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucky, O.O., Omonkhelin, O.J. In vitro tocolytic activity of 3-benzamido-1-(4-(2-methoxyphenyl)-piperazin-1-yl)-propyl-2-isopropylcarboxamide. Pharm Chem J 43, 16–18 (2009). https://doi.org/10.1007/s11094-009-0237-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-009-0237-8

Key words

Navigation